- Sixth Wave (SIXW) has successfully demonstrated binding and detection of SARS-CoV-2 virus in saliva samples using its AMIPs™ technology
- The company along with researchers at the La Ki Shing Institute of Virology are currently testing saliva samples spiked with live SARS-CoV-2 virus
- The next and final stage of laboratory-based development and viral selectivity screening, has commenced
- Completion of the cross-reactivity testing is required to begin the process of applying for regulatory approval
- Sixth Wave is a nanotechnology company
- Sixth Wave Innovations Inc. (SIXW) is down 4 per cent, trading at C$0.24 per share at 10:40 am EST
Sixth Wave (SIXW) has successfully demonstrated binding and detection of the SARS-CoV-2 virus in saliva samples using its AMIPs™ technology.
The company along with researchers at the La Ki Shing Institute of Virology are currently testing with Sixth Wave’s patent-pending Accelerated Molecularly Imprinted Polymer technology (AMIPs) using saliva samples spiked with live SARS-CoV-2 virus.
Detection of the virus in saliva samples is a critical deliverable in the development of the AMIPs technology.
Positive detection results have been achieved at increasingly lower viral loads and are nearing levels indicative of those present in people actively contagious with COVID-19. The results have been independently verified.
“The rapid progress of the AMIPs™ technology has been remarkable,” said Dr. Mike Joyce, a virologist at the La Ki Shing Institute of Virology.
“In a very short time, this technology has progressed from something that was very much basic research and non-existent in the diagnostic field to the cusp of real products capable of helping in the fight against COVID-19,” he added.
The next and final stage of laboratory-based development and viral selectivity screening has commenced. Experiments are being run against representative enveloped and non-enveloped viruses. Completion of the cross-reactivity testing is the last scientific development step required to produce specificity data before the company can begin the process of applying for regulatory approval from government agencies such as the FDA and Health Canada.
Sixth Wave is a nanotechnology company with patented technologies that focus on the extraction and detection of target substances at the molecular level.
Sixth Wave Innovations Inc. (SIXW) is down 4 per cent, trading at C$0.24 per share at 10:40 am EST.